Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 736-744

  Velázquez, F Raúl ^a   Colindres, Romulo E ^b   Grajales, Concepción ^a   Hernández, M Teresa ^a   Mercadillo, María Guadalupe ^a   Torres, F Javier ^a   Cervantes Apolinar, Mariayolanda ^c,d   Deantonio Suarez, Rodrigo ^b   Ortega Barria, Eduardo ^d   Blum, Maxim ^b   Breuer, Thomas ^b   Verstraeten, Thomas ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c GLAXOSMITHKLINE   (Mexico)

^d Estrada dos Bandeirantes   (Brazil)

Author keywords

Human rotavirus vaccine; Intussusception; Mexico; Postmarketing surveillance

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; FEMALE; HUMAN; INFANT; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MEXICO; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT;

DRUG TOXICITY; FEMALE; HUMANS; INFANT; INTUSSUSCEPTION; MALE; MEXICO; PRODUCT SURVEILLANCE, POSTMARKETING; PROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84862744065     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318253add3     Document Type: Article

References (42)

1. Velázquez FR, Garcia-Lozano H, Rodriguez E, et al. Diarrhea morbidity and mortality in Mexican children: impact of rotavirus disease. Pediatr Infect Dis J. 2004;23(suppl 10):S149-S155. (Pubitemid 44146424)
2. Quintanar-Solares M, Yen C, Richardson V, et al. Impact of rotavirus vaccination on diarrhea-related hospitalizations among children
3. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362:299-305.
4. Richardson V, Parashar U, Patel M. Childhood diarrhea deaths after rotavirus vaccination in Mexico. N Engl J Med. 2011;365:772-773.
5. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48:1007
6. Centers for Disease Control and Prevention. Suspension of rotavirus vaccine after reports of intussusception-United States, 1999. MMWR Morb Mortal Wkly Rep. 2004;53:786-789
7. Patel MM, Haber P, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines. 2009;8:1555-1564.
8. Murphy TV, Gargiullo PM, Massoudi MS, et al.; Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564-572. (Pubitemid 32167870)
9. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. (Pubitemid 43048947)
10. Instituto Mexicano del Seguro Social (IMSS). Available at: http://www. imss.gob.mx/estadisticas/dis/Pages/default.aspx. Accessed February 2012.
11. Instituto Mexicano del Seguro Social (IMSS). Births in Mexico, 1 October 2007. Available at: http://www.paho.org/english/sha/prflmex.htm. Accessed February 1, 2012.
12. Pan American Health Organization (PAHO). Mexico: country health profile. Available at: http://www.paho.org/english/sha/prflmex.htm. Accessed February 1, 2012.
13. Bines JE, Kohl KS, Forster J, et al.; Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine. 2004;22:569-574. (Pubitemid 38114883)
14. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768-1797.
15. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549-556. (Pubitemid 10242750)
16. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51:228-235.
17. Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364:2283-2292.
18. Buttery JP, Danchin MH, Lee KJ, et al.; PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29:3061-3066.
19. Bines JE, Patel M, Parashar U. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis. 2009;200(suppl 1):S282-S290.
20. Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine. 2004;22:2064-2070. (Pubitemid 38581081)
21. Cameron JC, Walsh D, Finlayson AR, et al. Oral polio vaccine and intussusception: a data linkage study using records for vaccination and hospitalization. Am J Epidemiol. 2006;163:528-533.
22. Macias M, Lopez P, Velazquez FR, et al. The rotavirus vaccine Rix 4414 (Rotarix) is not associated with intussusception in one year old infant. Poster G-841. In: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Washington DC, December 16-19, 2005. Washington, DC: American Society for Microbiology, 2005.
23. Parashar UD, Gibson CJ, Bresee JS, et al. Rotavirus and severe childhood diarrhea. Emerging Infect Dis. 2006;12:304-306.
24. World Health Organization. Rotavirus vaccines. WHO position paper. Wkly Epidemiol Rec. 2007;82:285-296.
25. Centers for Disease Control and Prevention. Rotavirus surveillance-worldwide, 2001-2008. MMWR Morb Mortal Wkly Rep. 2008;57:1255-1257.
26. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009;200(suppl 1):S9-S15.
27. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007;370:1757-1763. (Pubitemid 350137490)
28. Linhares AC, Velázquez FR, Pérez-Schael I, et al.; Human Rotavirus Vaccine Study Group. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet. 2008;371:1181-1189. (Pubitemid 351458523)
29. Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009;27:5936-5941.
30. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289-298.
31. Gurgel RG, Bohland AK, Vieira SC, et al. Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program. Gastroenterology. 2009;137:1970-1975.
32. O'Ryan M, Linhares AC. Update on Rotarix: an oral human rotavirus vaccine. Expert Rev Vaccines. 2009;8:1627-1641.
33. Correia JB, Patel MM, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363-369.
34. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
35. Lanzieri TM, Costa I, Shafi FA, et al. Trends in hospitalizations from all-cause gastroenteritis in children younger than 5 years of age in Brazil before and after human rotavirus vaccine introduction, 1998-2007. Pediatr Infect Dis J. 2010;29:673-675.
36. Yen C, Armero Guardado JA, Alberto P, et al. Decline in rotavirus hospitalizations and health care visits for childhood diarrhea following rotavirus vaccination in El Salvador. Pediatr Infect Dis J. 2011;30(suppl 1):S6-S10.
37. Lanzieri TM, Linhares AC, Costa I, et al. Impact of rotavirus vaccination on childhood deaths from diarrhea in Brazil. Int J Infect Dis. 2011;15:e206-e210.
38. do Carmo GM, Yen C, Cortes J, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8:e1001024.
39. Centers for Disease Control and Prevention. Statement regarding Rotarix® and RotaTeq® rotavirus vaccines and intussusception. Available at: http://www.cdc.gov/vaccines/vpd-vac/rotavirus/intussusception-studies-acip. htm. Accessed February 2012.
40. Department of Health and Human Services, Centers for Disease Control and Prevention. Summary report from the Meeting of the Advisory Committee for Immunization Practices (ACIP), October 27-28, 2010. Available at: http://www.cdc.gov/vaccines/recs/acip/downloads/min-archive/min-oct10. pdf. Accessed February 2012.
41. Meeting of the Global Advisory Committee on Vaccine Safety, December 2010. Wkly Epidemiol Rec.2011;86:38-43.
42. Rotavirus vaccine and intussusception: report from an expert consultation. Wkly Epidemiol Rec.2011;86:317-321.